Suppliers / Phytex Australia

Phytex Australia

Australia 14 employees Updated 9 July 2026

Phytex Australia is an API manufacturer based in Australia. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Methscopolamine Bromide US FDA 1
Scopolamine US FDA 1

Also appears on these molecule pages

Scopolamine API

Questions about Phytex Australia

Does Phytex Australia hold a US DMF or a CEP?
Phytex Australia holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Phytex Australia make?
2 molecules are on record against Phytex Australia, including Methscopolamine Bromide and Scopolamine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Phytex Australia comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Fine Chemicals Corporation (PTY) shares 1 molecule Alchem International shares 1 molecule Alkaloids shares 1 molecule Phytex Australia Pty shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability